877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes

por Taiwo, Babafemi O, Tan, Darrell, Patel, Parul, Teichner, Paula, Polli, Joseph, Garside, Louise, D’Amico, Ronald, Talarico, Christine L, Van Solingen-Ristea, Rodica, Baugh, Bryan, Spreen, William, Aboud, Michael, Bosse, Matthew
Publicado 2021

1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development

por Maas, Brian, Aliprantis, Antonios, Wolford, Dennis, Fayad, Ghassan, Vora, Kalpit, Geng, Dong, Ma, Hua, Caro, Luzelena
Publicado 2018

888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence

por Acosta, Rima K, Mulato, Andrew, D’Antoni, Michelle L, Yant, Stephen R, Cihlar, Tomas, White, Kirsten L
Publicado 2021

1145. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US

por Cheng, Mindy M, Gibbons, Daniel C, Birch, Helen, Patel, Vishal, Bell, Christopher F, Drysdale, Myriam, Satram, Sacha, Reyes, Carolina M
Publicado 2022

LB13. The Efficacy and Impact in Heathy Infants of Nirsevimab on Medically Attended RSV Lower Respiratory Tract Infection

por Hammitt, Laura, Hammitt, Laura, Dagan, Ron, Yuan, Yuan, Cots, Manuel Baca, Bosheva, Miroslava, Mahdi, Shabhir A, Muller, William J, Muller, William J, Zar, Heather J, Brooks, Dennis, Grenham, Amy, Hamrén, Ulrika Wählby, Mankad, Vaishali S, Ren, Pin, Takas, Therese, Heinrichs, Jon, Leach, Amanda, Griffin, M Pamela, Villafana, Tonya L
Publicado 2021

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy...

por Peterson, James, Drazan, Daniel, Czajka, Hanna, Maguire, Jason, Pregaldien, Jean-Louis, Seppa, Ilkka, Maansson, Roger, O’Neill, Robert, Anderson, Annaliesa S, Balmer, Paul, Beeslaar, Johannes, Perez, John L
Publicado 2020

162. CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models

por Döhrmann, Simon, Almaguer, Amanda, Dedeic, Nicholas, Amundson, Karin, Shathia, Kim, Brady, Thomas P, Noncovich, Alain, Zhao, Qiping, Hough, Grayson, Borchardt, Allen, Locke, Jeffrey B, Cole, Jason, Levin, James, Tari, Les
Publicado 2020

1021. HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week...

por Talarico, Christine L, Wu, Sterling, Upadhyay, Ojesh R, Clair, Marty St, Van Eygen, Veerle, Hudson, Krischan J, Griffith, Sandy, Harrington, Conn M, van Lunzen, Jan, Margolis, David, Spreen, William
Publicado 2020

543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical Studies

por Grobler, Jay, Strizki, Julie, Murgolo, Nicholas, Gao, Wei, Cao, Youfang, Zhang, Ying, Du, Jiejun, Nair, Manoj, Huang, Yaoxing, Luo, Yang, Hazuda, Daria, Ho, David D, Ho, David D
Publicado 2021

Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States

por McLaughlin, John, Khan, Farid, Curry, Aaron, Snow, Vincenza, Isturiz, Raúl, Swerdlow, David
Publicado 2017

Discovery of a Series of Potent and Selective Nucleotide Prodrug Inhibitors of Respiratory Syncytial Virus (RSV) Replication

por Good, Steven, Moussa, Adel, Meillon, Jean-Cristophe, Zhou, Xiao-Jian, Pietropaolo, Keith, Sommadossi, Jean-Pierre
Publicado 2017

Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years

por Chilson, Erica, Atkinson, Bruce, Hall-Murray, Cassandra, Snow, Vincenza, Schmoele-Thoma, Beate, Isturiz, Raúl E, Scott, Daniel A
Publicado 2017

1214. Household Transmission of Febrile Illness Measured by Smartphone-Connected Thermometers, United States, 2016-2021

por Bloch, Danielle, Zicker, John, Somhegyi, Hannah, Philips, Patrick, Singh, Inder, Daitch, Amy
Publicado 2021

A Single Dose Monoclonal Antibody (mAb) Immunoprophylaxis Strategy to Prevent RSV Disease in All Infants: Results of the First in Infant Study with MEDI8897

por Domachowske, Joseph B, Khan, Anis, Esser, Mark T, Jensen, Kathryn M, Takas, Therese, Villafana, Tonya, Dubovsky, Filip, Griffin, M Pamela
Publicado 2017

630. A 5-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19

por Buturovic, ljubomir, Khatri, Purvesh, Tang, Benjamin, Lai, Kevin, Kuan, Win Sen, Gillett, Mark, Santram, Rahul, Shojaei, Maryam, Almansa, Raquel, Nieto, Jose, Muñoz, Sonsoles, Herrero, Carmen, Antonakos, Nikolaos, Degree, Medical, Koufargyris, Panayiotis, Kontogiorgi, Marina, Damoraki, Georgia, Liesenfeld, Oliver, Wacker, James, Midic, Uros, Luethy, Roland, Rawling, David C, Remmel, Melissa, Coyle, Sabrina, Giamarellos, Evangelos J, Sweeney, Timothy
Publicado 2020

1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in...

por Bili, Adroniki, Dobson, Scott, Quinones, Jeffrey, Phongsamart, Wanatpreeya, Oberdorfer, Peninnah, Kosalaraksa, Pope, Dagan, Ron, Wilck, Marissa B, Vallejos, Waldimir, Nunn, Christine, McFetridge, Richard, Fu, Rong, Lupinacci, Robert, Musey, Luwy, Bickham, Kara
Publicado 2021

Are blockchain-based digital transformation and ecosystem-based business models mutually reinforcing? The principal-agent conflict perspective

por Ivaninskiy, Ilya, Ivashkovskaya, Irina
Publicado 2022

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With...

por Martinon-Torres, Federico, Rusch, Sarah, Huntjens, Dymphy, Remmerie, Bart, Vingerhoets, Johan, McFadyen, Katie, Ferrero, Fernando, Baraldi, Eugenio, Conejo, Pablo Rojo, Epalza, Cristina, Stevens, Marita
Publicado 2018

1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy V...

por Cass, Lindsey, Davis, Amanda, Murray, Alison, Woodward, Kathy, Ito, Kazuhiro, Strong, Pete, Rapeport, Garth
Publicado 2018

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations

por Lawrence, Jody, Kitchin, Nicholas, Anderson, Annaliesa S, Pride, Michael W, Jansen, Kathrin U, Gruber, William C, Peng, Yahong, Yi, Kevin, Knirsch, Charles, Webber, Chris
Publicado 2020